Dasman Diabetes Institute is hosting the 2nd GCC INCONET event, which is a 2-day meeting dedicated to strengthening the cooperation activities between EU and Gulf Countries Cooperation and to support the institutional, bi-regional strategic planning and policy dialogue in Healthcare and Science &Technology Innovation system. The meeting was attended by former Minister of Health, Dr. Hilal Al Sayer as well as Dr. Kazem Behbehani, Director-General of Dasman Diabetes Institute and many other dignitaries.
The event taking place at Dasman Diabetes Institute, Kuwait, on the 10th and 11th of June 2014, is a is a three-year (2014-2017) project sponsored by the European Commission – Directorate General for Research and Innovation which seeks to engage and collaborate with research-oriented institutions and organisations in science and technology-based projects relevant to the GCC region.
INCONET-GCC2, made up of 20 members, is a Science, Technology and Innovation International Cooperation Network between EU and the Arab Gulf Countries. Its main goal is to support the institutional, bi-regional policy dialogue in Science, Technology and Innovation (STI). Its other goals are to strengthen the bi-regional cooperation between research and innovation stakeholders, especially in the context of the Horizon 2020 program, and to monitor progress in the bi-regional STI cooperation.
It aims to promote joint research through clustering activities within the fields of Health Innovation, Energy Security & Innovation, Social Innovation, ICT, Water and Food and to identify specific thematic areas of mutual interest. INCONET-GCC2 aims to:
• Reinforce strategic S&T cooperation and innovation with the Arab Gulf region
• Facilitate access to knowledge, resources and markets in the GCC region
• Have a positive influence on the joint EU-GCC STI agenda
• Make it easier for Europe’s researchers and universities to work with the best scientists and research infrastructures in the world
• Create a roadmap for future research activities & collaborations
• Contribute effectively to stability, security and prosperity in the world
• Contribute to global sustainable development and foster Europe’s S&T excellence
• Contribute to the free circulation of knowledge at the global level
• Raise Europe’s S&T profile in the GCC region
Dr. Hilal Al-Sayer, as Chairman of the Board of Trustees of Dasman Diabetes Institute, and the Dasman International Scientific Advisory Board, said: “The significance of this conference lies in the startling fact that diabetes is now a global epidemic. Current estimates indicate that 382 million adults aged between 20 to 79 years are diagnosed with diabetes worldwide, while 316 million are diagnosed with impaired glucose tolerance. An additional 175 million are estimated to be undiagnosed. Each year, over 70,000 children develop diabetes and 440,000 children worldwide under the age of 14 now live with type 1 diabetes. In the Middle Eastern and North African Region 1 in 10 adults are diagnosed with diabetes.
Dr. Kazem Behbehani, Director General of Dasman Diabetes Institute welcomed in his speech the dignitaries who came from Europe, Gulf Countries and the Belgium Ambassador to Kuwait, who are participating in the event. Dr. Behbehani reiterated that this event sheds light on the epidemiology of diabetes and methods of combating it.